1,261 Matching Annotations
  1. Feb 2021
    1. Channel 4 News. (2021, January 17). “It’s working in mainland China with 1.4 billion people. It doesn’t depend on being an island.” A pandemic adviser to the New Zealand government says achieving zero cases isn’t about the size of a country, but about “strong leadership”. Https://t.co/SSpc8DjZXi [Tweet]. @Channel4News. https://twitter.com/Channel4News/status/1350834342709358593

    1. Youyang Gu. (2021, February 24). When can we return to normal? Forget about ‘herd immunity’. Below is my estimate for the number of susceptible individuals over time, as a proportion of the US population. Looking at this graph, what is the best point to go back to normal? Christmas? Fall? Or Summer? 🧵 https://t.co/V4uiFk5YcP [Tweet]. @youyanggu. https://twitter.com/youyanggu/status/1364627872233750543

    1. Dr Ellie Murray. (2020, December 3). Some really great resources & discussions in this thread. The tl;dr is (1) yes, the vaccine trials included some people who had previously had COVID; and (2) in general vaccination plans will include those who have previously been sick/infected. Thanks all! [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1334545373126389766

    1. ReconfigBehSci. (2021, January 18). Calling lawyers, historians, and political scientists. A thread on the value of life. I’m still stunned by Lord Sumption, ex-judge on UK’s Supreme Court, now anti-lockdown campaigner, publicly stating that the life of a woman with stage 4 bowel cancer was ‘less valuable’ 1/4 [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1351118909886312449

    1. Shen, X., Tang, H., McDanal, C., Wagh, K., Fischer, W. M., Theiler, J., Yoon, H., Li, D., Haynes, B. F., Saunders, K. O., Gnanakaran, S., Hengartner, N. W., Pajon, R., Smith, G., Dubovsky, F., Glenn, G. M., Korber, B. T., & Montefiori, D. C. (2021). SARS-CoV-2 Variant B.1.1.7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines (SSRN Scholarly Paper ID 3777473). Social Science Research Network. https://papers.ssrn.com/abstract=3777473

  2. Jan 2021
  3. Dec 2020
    1. Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, C. J. A., … Zuidewind, P. (2020). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)32661-1

  4. Nov 2020
  5. Oct 2020
  6. Sep 2020
  7. Aug 2020
    1. Hewitt, J., Carter, B., Vilches-Moraga, A., Quinn, T. J., Braude, P., Verduri, A., Pearce, L., Stechman, M., Short, R., Price, A., Collins, J. T., Bruce, E., Einarsson, A., Rickard, F., Mitchell, E., Holloway, M., Hesford, J., Barlow-Pay, F., Clini, E., … Guaraldi, G. (2020). The effect of frailty on survival in patients with COVID-19 (COPE): A multicentre, European, observational cohort study. The Lancet Public Health, 5(8), e444–e451. https://doi.org/10.1016/S2468-2667(20)30146-8

    1. Altig, D., Baker, S. R., Barrero, J. M., Bloom, N., Bunn, P., Chen, S., Davis, S. J., Leather, J., Meyer, B. H., Mihaylov, E., Mizen, P., Parker, N. B., Renault, T., Smietanka, P., & Thwaites, G. (2020). Economic Uncertainty Before and During the COVID-19 Pandemic (Working Paper No. 27418; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27418